Stay updated on Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page’s ClinicalTrials.gov interface revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site tooling update rather than a change to the trial’s record data.
    Difference
    0.1%
    Check dated 2026-04-24T22:42:43.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the history.
    Difference
    0.1%
    Check dated 2026-04-17T14:19:05.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page history now shows a new revision labeled v3.5.0, while the previous revision v3.4.3 is no longer listed.
    Difference
    0.1%
    Check dated 2026-03-19T23:54:50.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Added revision entry v3.4.3 and removed v3.4.2 from the history.
    Difference
    0.1%
    Check dated 2026-03-05T18:52:46.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    - The record history shows a new revision v3.4.2 added and v3.4.1 removed, indicating a minor update to the page’s revision history. There are no visible changes to study data or page content.
    Difference
    0.1%
    Check dated 2026-02-12T01:53:12.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    The page history now shows an addition of Revision: v3.4.1 and removal of Revision: v3.4.0, reflecting a minor update to the record’s version history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:35:55.000Z thumbnail image

Stay in the know with updates to Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.